Study of CT071 Injection in High Risk Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Cohort Construction and Prognostic Model Construction for Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of SYS6020 in BCMA-positive Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Real-World Study of Bispecific Antibodies in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Status
- RECRUITING
- Phase
- N/A
Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM
- Status
- WITHDRAWN
- Phase
- PHASE2
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
- Status
- RECRUITING
- Phase
- N/A
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE2
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Status
- RECRUITING
- Phase
- NA
Precision Medicine Study
- Status
- COMPLETED
- Phase
- N/A
Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A